Abbott Laboratories Stock Revenue
| ABT Stock | USD 107.28 2.01 1.91% |
Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 40.1 B | 22.2 B |
Abbott | Revenue |
Abbott Laboratories Company Revenue Analysis
Abbott Laboratories' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Abbott Laboratories Revenue | 40.11 B |
Most of Abbott Laboratories' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Abbott
Projected quarterly revenue analysis of Abbott Laboratories provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Abbott Laboratories match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Abbott Laboratories' stock price.
Abbott Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Abbott Stock properly, considering its historical fundamentals such as Revenue. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.
| -0.07 | -0.13 | -0.58 | -0.12 | 0.68 | ||
| -0.07 | 0.99 | 0.74 | 0.89 | 0.04 | ||
| -0.13 | 0.99 | 0.73 | 0.87 | 0.0 | ||
| -0.58 | 0.74 | 0.73 | 0.74 | -0.41 | ||
| -0.12 | 0.89 | 0.87 | 0.74 | 0.18 | ||
| 0.68 | 0.04 | 0.0 | -0.41 | 0.18 |
Click cells to compare fundamentals
Abbott Revenue Historical Pattern
Today, most investors in Abbott Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abbott Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abbott Laboratories revenue as a starting point in their analysis.
Abbott Laboratories Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Abbott Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Abbott Laboratories reported 40.11 B of revenue. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is significantly lower than that of the firm.
Abbott Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in revenue category among related companies.
Abbott Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Abbott Laboratories Institutional Holders
Institutional Holdings refers to the ownership stake in Abbott Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abbott Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abbott Laboratories' value.| Shares | Wells Fargo & Co | 2023-12-31 | 16.5 M | Bank Of America Corp | 2023-12-31 | 16.4 M | Bank Of New York Mellon Corp | 2023-12-31 | 15.1 M | Legal & General Group Plc | 2023-12-31 | 14.3 M | State Farm Mutual Automobile Ins Co | 2023-12-31 | 13.6 M | Polen Capital | 2023-12-31 | 13.5 M | Jpmorgan Chase & Co | 2023-12-31 | 13.3 M | Hhg Plc | 2023-12-31 | 13.2 M | Nuveen Asset Management, Llc | 2023-12-31 | 12.4 M | Vanguard Group Inc | 2023-12-31 | 156.4 M | Blackrock Inc | 2023-12-31 | 134.1 M |
Abbott Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0611 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 191.48 B | ||||
| Shares Outstanding | 1.74 B | ||||
| Shares Owned By Insiders | 0.53 % | ||||
| Shares Owned By Institutions | 77.02 % | ||||
| Number Of Shares Shorted | 14.48 M | ||||
| Price To Earning | 24.14 X | ||||
| Price To Book | 4.90 X | ||||
| Price To Sales | 4.72 X | ||||
| Revenue | 40.11 B | ||||
| Gross Profit | 24.58 B | ||||
| EBITDA | 10.59 B | ||||
| Net Income | 5.7 B | ||||
| Cash And Equivalents | 9.88 B | ||||
| Cash Per Share | 5.68 X | ||||
| Total Debt | 15.87 B | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | 22.26 X | ||||
| Cash Flow From Operations | 7.26 B | ||||
| Short Ratio | 2.26 X | ||||
| Earnings Per Share | 3.21 X | ||||
| Price To Earnings To Growth | 5.99 X | ||||
| Target Price | 119.18 | ||||
| Number Of Employees | 114 K | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 182.66 B | ||||
| Total Asset | 73.21 B | ||||
| Retained Earnings | 37.55 B | ||||
| Working Capital | 8.83 B | ||||
| Current Asset | 14.15 B | ||||
| Current Liabilities | 9.19 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.54 % | ||||
| Net Asset | 73.21 B | ||||
| Last Dividend Paid | 2.12 |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Abbott Laboratories Investors Sentiment
The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with an investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbott Laboratories.
Abbott Laboratories Implied Volatility | 59.19 |
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.
Pair Trading with Abbott Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving against Abbott Stock
| 0.44 | GCTK | GlucoTrack | PairCorr |
| 0.43 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.